Outcome map · Supplement

Migraine frequency: what the evidence supports

2 graded interventions for migraine frequency, ranked by strength of evidence.

Overall grade
Grade B
Last revised
2
graded outcomes
0
references listed

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade B · 1 at grade C — 2 graded rows

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Riboflavin (B2)Evidence grade B

    400 mg/day

    Moderatemixed

  • FeverfewEvidence grade C

    Inconsistent

    Smallmixed

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Feverfew (grade C).
  • Studies disagree: Riboflavin (B2) (mixed agreement).

The evidence in words

The evidence map

This is the ranked evidence for migraine frequency: every compound in the knowledge base with a graded effect, best-supported first. Grades reflect replication and effect size, not popularity or marketing.

Best-supported

Riboflavin (B2) (grade B) — 400 mg/day

Weaker or unproven

Feverfew (grade C) — Inconsistent

Goes with

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised . A grade is this entry's reading of the evidence, not medical advice.